HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decrease of FGF19 contributes to the increase of fasting glucose in human in an insulin-independent manner.

AbstractPURPOSE:
The ileum-derived fibroblast growth factor 19 (FGF19) plays key roles in hepatic glucose homeostasis in animals in an insulin-independent manner. Here, we analyzed the association of FGF19 with glucose effectiveness (GE, the insulin-independent glucose regulation), as well as hepatic glucose production (HGP) in Chinese subjects.
METHODS:
GE was measured by frequently sampled intravenous glucose tolerance test (FSIVGTT) in normal glucose tolerance (NGT), isolated-impaired glucose tolerance (I-IGT), and isolated-impaired fasting glucose (I-IFG) subjects. The oral glucose tolerance test-derived surrogate of GE (oGE) was determined in NGT, I-IFG, combined glucose intolerance (CGI), and type 2 diabetes (T2DM) subjects. HGP was assessed by labeled ([3-3H]-glucose) hyperinsulinemic-euglycemic clamp in NGT subjects. Insulin secretion and sensitivity were calculated by the hyperglycemic and hyperinsulinemic-euglycemic clamps in a subgroup of NGT, I-IGT, and I-IFG subjects. Serum FGF19 levels were determined by ELISA.
RESULTS:
FGF19 positively correlated with GE (r = 0.29, P = 0.004) as determined by FSIVGTT. The result was further confirmed by oGE (r = 0.261, P < 0.001). FGF19 was negatively associated with FPG (r = - 0.228, P = 0.025), but the association no longer existed after adjusting for GE (r = - 0.177, P = 0.086). FGF19 was negatively associated with basal HGP (r = - 0.697, P = 0.006). However, the correlation between FGF19 and insulin secretion and sensitivity were not found.
CONCLUSIONS:
FGF19 levels are associated positively with GE and negatively with HGP. The increase of FPG in human is at least partially due to the decrease of FGF19 in an insulin-independent manner.
AuthorsJ Zhang, H Li, N Bai, Y Xu, Q Song, L Zhang, G Wu, S Chen, X Hou, C Wang, L Wei, A Xu, Q Fang, W Jia
JournalJournal of endocrinological investigation (J Endocrinol Invest) Vol. 42 Issue 9 Pg. 1019-1027 (Sep 2019) ISSN: 1720-8386 [Electronic] Italy
PMID30852757 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Blood Glucose
  • FGF19 protein, human
  • Insulin
  • Fibroblast Growth Factors
Topics
  • Adult
  • Biomarkers (analysis)
  • Blood Glucose (analysis)
  • Fasting (physiology)
  • Female
  • Fibroblast Growth Factors (metabolism)
  • Follow-Up Studies
  • Glucose Clamp Technique
  • Glucose Intolerance (physiopathology)
  • Glucose Tolerance Test
  • Humans
  • Insulin (metabolism)
  • Insulin Resistance
  • Male
  • Middle Aged
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: